Evaluating the Aβ-index as an estimate of Aβ load

Takeaway

  • The proposed amyloid-beta (Aβ) index is very well associated with standardized uptake value ratios (SUVR) and may be simpler to implement in clinical settings, because it does not require magnetic resonance imaging (MRI) nor definition of regions of interest (ROI).

Why this matters

    SUVR is the most commonly used quantitative measure for Aβ–positron emission tomography (PET) tracers and requires delineation of ROI through high-resolution MRI, which may not always be available or may be contraindicated; the Aβ-index is proposed as a novel measure of brain Aβ-burden that may be simpler to implement in clinical practice.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.